In this video module, Program Director Nadia Harbeck and Patient Advocate Renate Haidinger discuss the importance of shared decision making throughout the course of a patient’s treatment, including the communication of risk, and decisions on testing, therapies and adverse event management.
After completing this activity, you will be able to:
- Discuss best practice for communicating about recurrence risk and treatment options with those diagnosed with HR+/HER2- early breast cancer
- Integrate tools and guidance on shared decision making to ensure patient preference is a high priority when choosing the management strategy
Download the communication aid
Nadia and Renate’s conversation has been summarised into a practical communication aid, listing key considerations from both the clinician and patient point of view for shared decision making with HR+/HER2- early breast cancer patients.
Please select your preferred language to access the communication aid.
Sign up for new content alerts
Enter your email address below and we'll contact you as soon as new content is launched!